🇺🇸 FDA
Patent

US 10548905

Amorphous onapristone compositions and methods of making the same

granted A61KA61K31/575A61K9/146

Quick answer

US patent 10548905 (Amorphous onapristone compositions and methods of making the same) held by CONTEXT BIOPHARMA, INC. expires Mon Jan 30 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
CONTEXT BIOPHARMA, INC.
Grant date
Tue Feb 04 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 30 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
7
CPC classes
A61K, A61K31/575, A61K9/146, A61K9/1635, A61K9/1641